Washington — President Trump on Monday signed an executive order designating illicit fentanyl as a weapon of mass destruction, directing the Pentagon and Justice Department to take additional steps to ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

NEW YORK — Welcome to exhausted America 2025: Most adults are more than a little fine with doling out cash as gifts, and many plan to be asleep before midnight on New Year’s Eve, according to a new AP ...

President Donald Trump signed an executive order on Monday, Dec. 15, designating Fentanyl as a weapon of mass destruction. The order would allow the U.S. to expand even further its militarization of ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, Recursion announced positive Phase 1b/2 results for REC-4881, which is its ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

WASHINGTON ‒ President Donald Trump has taken action classifying fentanyl as a "weapon of mass destruction" as his administration escalates efforts to combat the flow of illicit drugs into the United ...

Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.

When Sam Darnold threw his second interception Thursday night, there was no reason to believe the Seattle Seahawks could come back. The Los Angeles Rams had clearly been the better team. Darnold was ...

President Donald Trump’s approval rating was stagnant in one poll, improved in another and declined slightly in a third, in new polls that overlapped with his administration’s stunning capture of ...